Table 5. Patients undergoing radical treatment according to staging category.
| PET-CT confirming CTS findings of M0 disease n=147 (%) | PET-CT refutes CT evidence of possible metastases n=25 (%) | PET-CT recommends additional staging investigations n=23 (%) | |
|---|---|---|---|
| Radical treatment started |
108 (73.5) |
18 (72.0) |
17 (73.9) |
| Radical treatment not started |
39 (26.5) |
7 (28.0) |
6 (26.1) |
| Unfit for radical treatment | 22 (56.4) | 5 (71.4) | 1 (1.7) |
| Other staging investigation(s) demonstrated advanced disease |
5 (12.8) |
1 (14.3) |
4 (66.6) |
| Patient choice | 3 (7.7) | 0 (0) | 1 (1.7) |
| Unknown |
6 (15.4) |
1 (14.3) |
0 (0) |
| Radical treatment completed |
96 (88.9) |
18 (100) |
14 (82.4) |
| Radical treatment not completed | 13 (12.0) | 0 (0) | 3 (17.6) |
| Disease progression during neoadjuvant treatment | 8 (61.5) | 0 (0) | 1 (33.3) |
| Toxicity during neoadjuvant treatment | 1 (7.7) | 0 (0) | 0 (0) |
| Inoperability at planned surgery | 4 (30.8) | 0 (0) | 2 (66.7) |
Abbreviations: CTS=computerised tomography; PET-CT=fluorodeoxyglucose positron emission tomography-computed tomography.